Table 2 Performance characteristics of EPI-CE at the 15.6 cut-point.

From: Validation of a CE-IVD, urine exosomal RNA expression assay for risk assessment of prostate cancer prior to biopsy

 

EPI-CE (N = 109), mean (95% CI)

Samples below cut-point

25% (17–34%)

Sensitivity

92% (79–98%)

Specificity

34% (23–46%)

False negative rate (> GG2)

8% (2–21%)

False negative rate (> GG3)

3% (0–14%)

Negative Predictive value

89% (71–98%)

Positive Predictive value

43% (32–54%)

Back to article page